Nephrol Dial Transplant

• 

  Publication Venue For

  • Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE)..  38:894-903. 2023
  • The ASCEND-ND trial: study design and participant characteristics..  37:2157-2170. 2022
  • The modifying effect of the serum-to-dialysate potassium gradient on the cardiovascular safety of SSRIs in the hemodialysis population: a pharmacoepidemiologic study..  37:2241-2252. 2022
  • Semiquantitative assessed proteinuria and risk of heart failure: analysis of a nationwide epidemiological database..  37:1691-1699. 2022
  • Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial..  37:1317-1329. 2022
  • Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial..  37:960-972. 2022
  • Association of circulating cardiac biomarkers with electrocardiographic abnormalities in chronic kidney disease..  36:2282-2289. 2021
  • Clinical events and patient-reported outcome measures during CKD progression: findings from the Chronic Renal Insufficiency Cohort Study..  36:1685-1693. 2021
  • Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial..  36:111-120. 2021
  • The renin-angiotensin-aldosterone system update: full-court press..  35:1488-1490. 2020
  • Revamping the 'renal' diet: using foods to control phosphorus physiology..  34:1619-1622. 2019
  • The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia..  34:339-346. 2019
  • Risk profiles for acute health events after incident atrial fibrillation in patients with end-stage renal disease on hemodialysis..  33:1590-1597. 2018
  • Obesity and synergistic risk factors for chronic kidney disease in African American adults: the Jackson Heart Study..  33:992-1001. 2018
  • Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies..  33:310-318. 2018
  • Prognostic value of bone- and vascular-derived molecular biomarkers in hemodialysis and renal transplant patients: a systematic review and meta-analysis..  32:1566-1578. 2017
  • Intravenous iron administration strategies and anemia management in hemodialysis patients..  32:173-181. 2017
  • Chronic kidney disease in low- and middle-income countries..  31:868-874. 2016
  • Caring for patients with kidney disease: shifting the paradigm from evidence-based medicine to patient-centered care..  31:368-375. 2016
  • Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients..  30:2068-2075. 2015
  • Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study..  30:1534-1541. 2015
  • Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study..  30:829-835. 2015
  • Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: a comparative effectiveness analysis from the DEcIDE-ESRD study..  30:667-675. 2015
  • Impact of westernization on fibroblast growth factor 23 levels among individuals of African ancestry..  30:630-635. 2015
  • Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD..  29:2028-2035. 2014
  • Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial..  29:833-842. 2014
  • Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery..  28:2787-2799. 2013
  • Expression of fgf23 and αklotho in developing embryonic tissues and adult kidney of the zebrafish, Danio rerio..  27:4314-4322. 2012
  • Glycohemoglobin not as predictive as fasting glucose as a measure of prediabetes in predicting proteinuria..  27:3862-3868. 2012
  • Impact of higher hemoglobin targets on blood pressure and clinical outcomes: a secondary analysis of CHOIR..  27:3606-3614. 2012
  • Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study..  27:3270-3278. 2012
  • Retinal arteriolar caliber and urine albumin excretion: the Multi-Ethnic Study of Atherosclerosis..  26:3523-3528. 2011
  • Prevalence and predictors of proteinuria in HIV-infected and uninfected pregnant women in Cameroon..  26:3051-3053. 2011
  • Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort..  26:1258-1265. 2011
  • Race differences in access to health care and disparities in incident chronic kidney disease in the US..  26:899-908. 2011
  • Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease..  26:584-591. 2011
  • Racial differences in postprandial mineral ion handling in health and in chronic kidney disease..  25:3970-3977. 2010
  • Ethnic disparities in prevalence and impact of risk factors of chronic kidney disease..  25:2564-2570. 2010
  • Fractal analysis of the retinal vasculature and chronic kidney disease..  25:2252-2258. 2010
  • Perioperative outcomes among patients with end-stage renal disease following coronary artery bypass surgery in the USA..  25:2275-2283. 2010
  • Randomized evaluation of efficacy and safety of ferric carboxymaltose in patients with iron deficiency anaemia and impaired renal function (REPAIR-IDA): rationale and study design..  25:2368-2375. 2010
  • C-reactive protein and microalbuminuria in a multi-ethnic Asian population..  25:1167-1172. 2010
  • Elevated FGF-23 in a patient with rhabdomyolysis-induced acute kidney injury..  25:1335-1337. 2010
  • Socioeconomic status and microalbuminuria in an Asian population..  24:123-129. 2009
  • Thirteen novel NPHS1 mutations in a large cohort of children with congenital nephrotic syndrome..  23:3527-3533. 2008
  • Association between body mass index and chronic kidney disease in men and women: population-based study of Malay adults in Singapore..  23:1910-1918. 2008
  • Mutations in PLCE1 are a major cause of isolated diffuse mesangial sclerosis (IDMS)..  23:1291-1297. 2008
  • Mortality, kidney disease and cardiac procedures following acute coronary syndrome..  23:934-940. 2008
  • Genetic background influences cardiac phenotype in murine chronic kidney disease. 2018